PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “AGGLUTININS AND AGGLUTINATION”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 667 records · Page 37Linked to original sources

[Differences in certain immunological indices among persons who have had cholera and among Vibrio carriers].

Blood sera of persons, who sustained cholera of different degree of severity, and of vibrio-carriers, and also chromatographic fractions obtained in separation of the mentioned sera on DEAE-cellulose were investigated in the reaction of agglutination and the indirect hemagglutination test. Immunological response in the vibrio carriers was realized by the microglobulin, and in the convalescents--by the macroglobulin type. There was also revealed an association between the severity of the course of cholera and the prevalence in the blood serum of one or another type of specific antibodies: in severe forms of the disease the antibodies of the IgM-class were detected with the greatest frequency, and microglobulin antibodies--in vibrio carriers. The detected differences in the immunological status of those who sustained cholera and of vibrio-carriers could be used as an additional differential sign in the diagnosis of the mentioned conditions.

Acute Disease↗

[The agglutinability of cholera O-monoclonal immunoglobulins].

A set of 10 monoclonal antibodies specific for vibrio species and of 5 monoclonal antibodies specific for serovar (Ogawa) was studied. These monoclonal antibodies were directed toward V. cholerae O1 antigen in agglutination reaction and on slide plates. Monoclonal antibodies agglutinating typical strains of cholera vibrios with titration range from 1: 6000 to 1: 25,000 were selected. MA were revealed to interact with cholera vibrio strains with reduced agglutinability. The set of agglutinating O monoclonal immunoglobulins was developed for laboratory identification of cholera O1 vibrios.

Agglutination Tests↗

[Normal "irregular" hemagglutinins in the sera of healthy adults found by using increased volumens of serum in agglutination and conglutination tests (author's transl)].

Using increased volumens of serum [in the Multiple-Dosage (MD) or a High Dosage (HD) test] with a sensitive manual reading technique all sera of 37 donors of blood group A2 showed irregular anti-A1(alpha1) antibodies. With the same technique, up to 1/3 of the sera of 417 healthy blood donors agglutinated red cells of a selected antigen pattern at room temperature; at 4 degrees C the ratio of positive reacting sera was much higher. The specificity of the antibodies, as indicated by the antigramme type, could be confirmed in the most cases by reacting with a series of known positive and negative reference red cells. The eluates of some of the sera yielded the same antigramme pattern as the native sera did. Some of the antibodies showed a specificity corresponding to a red cell property of the respective blood donor; but not in each case the antibodies were capable to agglutinate the donor's cells. If "autoagglutinins" were strong, frequently they revealed a character of panagglutinability, particular in the cold. With the antiglobulin test, which followed the NaCl-MD procedure, the number of positive reactions increased; on the other hand, there were some of the previously positive agglutination tests, which became negative during the course of the AHG step.

ABO Blood-Group System↗

[Preparation of universal anti-rhesus sera using soluble synthetic group A and B substances].

Isohemagglutinins alpha and beta were neutralized by soluble synthetic group A and B substances in group ++anti-rhesus sera. The investigations conducted have shown that water-soluble polymers A and B are efficient agents for the preparation of universal ++anti-rhesus sera. The neutralizing properties of synthetic and natural group A and B substances were comparatively studied.

Agglutination Tests↗

[Tissue antagonist of interferon : murine substance similar to plant lectins].

A tissue antagonist of interferon (TAI) extracted from mouse costal cartilage contains a substance which has many properties characteristic of plant lectins. After binding to the cell membrane receptors, it agglutines normal and transformed murine cells. In interferon treated cells, it restores virus sensitivity probably through a modification in the distribution of membrane bound cellular antigens.

Agglutination Tests↗

[A new leptospiral serovar in the autumnalis serogroup].

Strain A6 of leptospire was isolated from blood culture of a case with leptospirosis on July 1, 1962 in Mengla county, Xishuangbanna, Yunnan. It is proved a new serovar belonging to serogroup Autumnalis by cross agglutination and cross agglutinin-absorption tests. The name, Leprospira interrogans serovar nanla with reference strain A6 is proposed.

Humans↗

Hepatic infections. Part II. The effect of acute and chronic hepatitis B antigenaemia on the reaction to antibodies to sheep red cells (microbial antigens) and human T-activated cells (exposed autologous tissue antigens).

Using the agglutination of sheep red cells by human antibodies as an indicator of microbial antibody activity, a highly significant association was found between the response to the e antigen of the hepatitis B virus and the formation of strong antibody levels to microbial substances (chi 2(1) = 33). This kind of association was not found among chronic carriers of the hepatitis B virus who do not produce antibodies to the e antigen (chi 2(1) = 3,7). In the presence of e antigen activity, patients with acute virus B hepatitis almost always show significantly reduced levels of antibodies to microbial substances (chi 2(1) = 20). The findings indirectly reveal that e activity is associated with the inability of the liver to trap bacterial antigens. Circumstantial evidence further suggests that the e factor may bear antigens on its immunoglobulin-like structure very similar to microbial cell wall components. Accepting that human antibodies to the T (Thomsen-Friedenreich) antigen represent reactions to cryptantigenic membrane structure of autologous tissues, it was significant to record that increased anti-t activity is always demonstrated when virus B infections progress from the acute to the chronic carrier stage (chi 2(1) = 73). The most intense anti-T activity is commonly found in subjects who produce antibodies to the hepatitis B surface antigen (chi 2(1) = 138). In the presence of e antigen the amount of anti-T in circulation is always significantly depressed. Since this type of depression is not seen in patients with acute virus B hepatitis who lack the e antigen, we suspect that the reduced anti-T levels in e antigen-positive patients are linked with the in vivo exposure of T receptors by microbial neuraminidase.

Acute Disease↗

[Agglutination reaction of T. cruzi, T. cruzi like Strains, T. rangeli and T. conorhini with Soja hispida lectin and Aaptos papillata protectin (author's transl)].

Protectin from the sponge Aaptos papillata (Keller) was used in the characterization of five strains of T. cruzi (Venezuela, Guatemala, Y. Brasilien, Peru, Wien) and six T. cruzi like strains (Triatoma, Maryland, ITMAP 943, FH4, FH5, LN). Based upon their membrane receptors, these T. cruzi and T. cruzi like isolates could be differentiated from rangeli (Venezuela Strain) and T. conorhini (Hawai Strain) by agglutination reaction to the proctectin. Furthermore, after pronase treatment T.rangeli could also be distinguished from T. conorhini by agglutination test with A. papillata protectin and also Soja hispida lectin. It is not possible to differentiate the T. cruzi complex with S. hispida lectin, because it did not agglutinate T. cruzi (Vienna Strain) and T. cruzi like (Maryland Strain). However, after treating this human pathogenic strain with pronase the pseudocrypt antigen of the first order is made available to the S. hispida lecting thereby producing agglutination. The T. cruzi like strain however did not agglutinate with this treatment. On the other hand, while T. rangeli did not agglutinate even after pronase treatment, T. conorhini showed the agglutination reaction. This observed reaction is explained by the availability of the pseudocrypt antigens of the first order after pronase treatment.

Agglutination Tests↗

[Phage conversion of escherichia and shigella antigens. I. Phage conversion of type I antigen of Sh. flexneri in entrophatogenic E. coli O129].

The authors realized conversion of type I Sh. flexneri in enteropathogenic E. coli O129 with converting moderate phage phi I Sh. flexneri. Phage phi I lysogenized 7.3--42.7% of the cells of antigenic E. coli variant O129 which lost type V antigen; conversion of the type I antigen of Sh. flexneri was revealed in the agglutination and adsorption of agglutinins tests. As a result, E. coli strain was obtained with the O-antigen identical to the O-antigen of Sh. flexneri Ia.

Bacteriophages↗

Antibodies to Coprococcus comes in sera of patients with Crohn's disease. Isolation and purification of the agglutinating antigen tested with an ELISA technique.

Previous studies showed that agglutinating antibodies to Coprococcus comes, an anaerobic Gram-positive coccoid rod isolated from the faecal flora of patients with Crohn's disease, are more frequently found in sera of Crohn patients than in ulcerative colitis patients and healthy subjects. Isolation of the antigen may be useful in developing a more sensitive and specific diagnostic test. The present study describes first a method to improve the presentation of the relevant agglutinating antigen by the bacterium and second, the purification by column chromatography of a relatively crude antigen extract of C. comes described previously by Hazenberg et al. (1). Comparative results with the agglutination reactions and ELISA technique of extensive series of patients with Crohn's disease and healthy subjects have shown that the agglutinating antigen of C. comes has been isolated. Although the present ELISA technique cannot replace the simple and reliable agglutination reaction for screening purposes, the purified antigen will allow further immunological studies and it is to be hoped that a deeper insight into pathogenesis of the disease will be gained.

Agglutination Tests↗

[Use of the immunofluorescent microagglutination reaction for the intrageneric differentiation of the immune response in chlamydiosis].

The possibility of using, on principle, the immunofluorescent microagglutination test with Chlamydia fluorescent corpuscular antigen for the strain-specific differentiation of immune response induced by the causative agents of ornithosis (strain B), enzootic abortus ovis (strain EAE) and lymphogranuloma venereum (strain LV) has been experimentally demonstrated. The calculation of indices, characterizing the specificity of differences between the systems under comparison, by the method of S. Frasser and D. Berman (1965) has confirmed the significance of such differentiation.

Agglutination Tests↗

Canine brucellosis in a household.

Three cases of canine brucellosis from the same household were discovered during a serosurvey of privately owned dogs. One dog was found to be seropositive and culture-positive, 1 dog was seropositive, and 1 dog had suspect test results, with eye lesions suggestive of Brucella canis infection. All dogs had signs seen with B canis infection, but none was pathognomonic. Although pathologic findings in 2 of the dogs were consistent with findings reported by other investigators, none was conclusive for brucellosis. The 2-mercaptoethanol tube agglutination test was utilized as the diagnostic test.

Agglutination Tests↗

Shedding of Coxiella burnetii in milk by Nigerian dairy and dual purposes cows.

Fresh milk from dairy cows kept at semi-intensive husbandry in governmental and institutional farms and dual purpose Fulani nomadic husbandry around Zaria, Nigeria were screened for Coxiella burnetii using the mouse inoculation test. Of the 20 herds from both management systems tested, 16(80.0%) contained dairy cows shedding C. burnetii in their milk. Of a total of 169 cows tested, 41(24.3%) were shedders. Eighteen (22.0%) of 82 cows kept under semi-intensive and 23(26.4%) of 87 cows kept under Fulani nomadic systems were shedding C. burnetii. The difference in frequency of shedding C. burnetii between both system was not statistically significant (P greater than 0.05, X2). Of the 88 dairy cows serologically tested for C. burnetii agglutinins by the capillary agglutination test (C.A.T), 48(54.5%) were sero-positive and 40(45.5%) were seronegative. Among Q-fever sero-positive cows, 11(22.9%) were shedders and 37(77.1%) were not shedding C. burnetii in their milk. Of the sero-negative cows, 6(15.0%) and 34(85.0%) were shedders and non-shedders, respectively. With milk from Fulani nomadic cows predominantly taken raw or made into unheated fermented milk products, the health risk to the consumers of such products cannot be over-emphasized.

Animal Husbandry↗